[go: up one dir, main page]

WO2019009628A3 - 화상 및 욕창의 완화 및 치료용 조성물 - Google Patents

화상 및 욕창의 완화 및 치료용 조성물 Download PDF

Info

Publication number
WO2019009628A3
WO2019009628A3 PCT/KR2018/007599 KR2018007599W WO2019009628A3 WO 2019009628 A3 WO2019009628 A3 WO 2019009628A3 KR 2018007599 W KR2018007599 W KR 2018007599W WO 2019009628 A3 WO2019009628 A3 WO 2019009628A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
bedsores
relieving
treating burns
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2018/007599
Other languages
English (en)
French (fr)
Other versions
WO2019009628A2 (ko
WO2019009628A9 (ko
Inventor
최성현
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipobiolab Corp
Original Assignee
Lipobiolab Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipobiolab Corp filed Critical Lipobiolab Corp
Priority to CN201880045545.0A priority Critical patent/CN110996977A/zh
Priority to EP18828213.1A priority patent/EP3650032A4/en
Priority to JP2020522655A priority patent/JP2020526585A/ja
Priority to US16/628,627 priority patent/US20200230179A1/en
Publication of WO2019009628A2 publication Critical patent/WO2019009628A2/ko
Publication of WO2019009628A3 publication Critical patent/WO2019009628A3/ko
Publication of WO2019009628A9 publication Critical patent/WO2019009628A9/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 동물 허파 조직 추출물을 유효성분으로 포함하는 화상 및 욕창의 완화 및 치료용 조성물에 관한 것으로, 본 발명의 조성물은 피부 손상에 대한 동물 허파 조직 추출물 및/또는 프로피온산의 보호 효과가 염증억제 뿐 아니라 섬유조직의 재생 및 혈관신생촉진과도 관련이 있음을 제시하여 피부 창상치유와 관련한 소재로써 유효성을 나타내며 화상 및 욕창치료와 관련되어 산업적으로 이용가능한 효과를 나타내서 이들 질환의 치료제로 사용될 수 있다.
PCT/KR2018/007599 2017-07-07 2018-07-04 화상 및 욕창의 완화 및 치료용 조성물 Ceased WO2019009628A2 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201880045545.0A CN110996977A (zh) 2017-07-07 2018-07-04 用于缓解或治疗灼伤及褥疮的组合物
EP18828213.1A EP3650032A4 (en) 2017-07-07 2018-07-04 COMPOSITION FOR THE RELIEF AND TREATMENT OF BURNS AND WOUNDS
JP2020522655A JP2020526585A (ja) 2017-07-07 2018-07-04 火傷及び褥瘡の緩和及び治療用組成物
US16/628,627 US20200230179A1 (en) 2017-07-07 2018-07-04 Composition for relieving and treating burns and bedsores

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0086354 2017-07-07
KR20170086354 2017-07-07

Publications (3)

Publication Number Publication Date
WO2019009628A2 WO2019009628A2 (ko) 2019-01-10
WO2019009628A3 true WO2019009628A3 (ko) 2019-04-11
WO2019009628A9 WO2019009628A9 (ko) 2019-05-31

Family

ID=64950171

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/007599 Ceased WO2019009628A2 (ko) 2017-07-07 2018-07-04 화상 및 욕창의 완화 및 치료용 조성물

Country Status (6)

Country Link
US (1) US20200230179A1 (ko)
EP (1) EP3650032A4 (ko)
JP (1) JP2020526585A (ko)
KR (1) KR102113754B1 (ko)
CN (1) CN110996977A (ko)
WO (1) WO2019009628A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102828750B1 (ko) 2022-05-12 2025-07-02 동의대학교 산학협력단 호박씨 성분을 포함하는 욕창 예방용 조성물 및 이를 포함하는 외용제

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024995A (en) * 1987-04-08 1991-06-18 Chiesi Farmaceutici S.P.A. Natural pulmonary surfactant, method of preparation and pharamceutical compositions
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
US20130150327A1 (en) * 2010-05-19 2013-06-13 Biopid Corporation Composition for preventing hair loss or stimulating hair growth
JP5602891B2 (ja) * 2004-12-21 2014-10-08 ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント 創傷治癒および組織再生を促進するための組成物および方法
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4305552A1 (de) * 1992-12-18 1994-06-23 Rhone Poulenc Rorer Gmbh Verwendung von Alkanolaminen
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
CA2537246A1 (en) * 2003-09-03 2005-03-17 Kringle Pharma Inc. Skin ulcer preventive or curative agent containing human recombinant hgf
GB0426010D0 (en) * 2004-11-26 2004-12-29 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
KR100891595B1 (ko) * 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
KR20080058126A (ko) 2006-12-21 2008-06-25 닛세이 바이오 카부시키 가이샤 창상 치료제, 욕창 치료제 또는 예방제, 화상 치료제
WO2009145982A1 (en) * 2008-04-01 2009-12-03 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
JP6425207B2 (ja) * 2014-10-16 2018-11-21 高田　任康 皮膚潰瘍の治療材

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024995A (en) * 1987-04-08 1991-06-18 Chiesi Farmaceutici S.P.A. Natural pulmonary surfactant, method of preparation and pharamceutical compositions
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
JP5602891B2 (ja) * 2004-12-21 2014-10-08 ムスク・ファウンデイション・フォー・リサーチ・ディベロップメント 創傷治癒および組織再生を促進するための組成物および方法
US20130150327A1 (en) * 2010-05-19 2013-06-13 Biopid Corporation Composition for preventing hair loss or stimulating hair growth
WO2016174269A1 (en) * 2015-04-30 2016-11-03 University Of Bremen A novel skin medical and cosmetic care product

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3650032A4 *

Also Published As

Publication number Publication date
EP3650032A4 (en) 2021-04-14
WO2019009628A2 (ko) 2019-01-10
CN110996977A (zh) 2020-04-10
KR102113754B1 (ko) 2020-05-20
EP3650032A2 (en) 2020-05-13
KR20190005764A (ko) 2019-01-16
US20200230179A1 (en) 2020-07-23
WO2019009628A9 (ko) 2019-05-31
JP2020526585A (ja) 2020-08-31

Similar Documents

Publication Publication Date Title
EA032439B9 (ru) Композиции и способы для лечения поверхностных ран
MX2016009063A (es) Preparacion farmaceutica que contiene compuesto de acido piridilaminoacetico.
WO2018094023A3 (en) Cyclic dipeptides and wound healing
EA201270747A1 (ru) Композиции и способы для профилактики и лечения ран
WO2019009628A3 (ko) 화상 및 욕창의 완화 및 치료용 조성물
JP2017537163A5 (ko)
JP6026540B2 (ja) 種々の原因の末梢性潰瘍の治療用組成物
CN101455748B (zh) 一种消炎生肌药及其制备方法
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
KR101374537B1 (ko) 곰보배추를 이용한 화상치료용 약학 조성물
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
Ryan The skin as a barrier: What does it mean when it fails when lymphoedema is present
EA201590825A1 (ru) Способы контролирования кровяного давления и снижения диспноэ при сердечной недостаточности
BR112018072164A2 (pt) composição farmacêutica, método para tratamento e/ou prevenção de uma doença de pele de um paciente e/ou para alívio dos sintomas da mesma, e, uso cosmético de uma composição
CN104306889A (zh) 一种治疗放射性皮炎的中药组合物粉剂及其制备方法
CN104306772B (zh) 一种治疗放射性皮炎的中药组合物及其制备方法
EA201900418A1 (ru) Средство для терапии раневых или ожоговых поражений кожи
MX2020001764A (es) Composicion farmaceutica para usarse en el aumento del cabello, la modificacion del cuero cabelludo o la piel, la cicatrizacion de una herida, la estimulacion de osteogenesis o la modificacion del cabello.
Rahmawati et al. International Journal of Medical Science and Clinical Research Studies
IN2012DE00315A (ko)
RU2005141738A (ru) Способ лечения ран
CN108096431A (zh) 一种烫伤外用涂剂
WO2019045286A3 (ko) 미퀠리아닌을 유효성분으로 포함하는 Th2-매개 면역질환의 예방 또는 치료용 조성물
MX2015008245A (es) Solucion coloidal de plata y camellia sinensis para el tratamiento de heridas infectadas de la piel.
GB2569902A (en) Herbal oil formulation for topical use and medicinal applications thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18828213

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2020522655

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018828213

Country of ref document: EP

Effective date: 20200207